Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
63 /100
HIGH RISK
Score updated Aug 28, 2026

XFOR — X4 Pharmaceuticals, Inc. Dilution Risk Tracker

Track XFOR dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track XFOR — Get alerts when the score changes →

As of August 28, 2026, X4 Pharmaceuticals, Inc. (XFOR) has a DilutionWatch DilutionScore of 63/100, rated HIGH dilution risk. X4 Pharmaceuticals, Inc. has a market capitalization of $406.52M, 99.15M shares outstanding, 82 institutional holders tracked. Stored dilution-related fields include 15.24M outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
80
💰 Cash Runway
25
📊 Float Risk
50
⚠️ Warrant Exposure
50
🔄 Convertible Debt
40

Dilution Forecast

Watch
Minor dilution signals detected
model est. 15%
📜 Warrant Exercise model 25%
• Significant warrants: 15% of shares outstanding
📉 Score Deterioration model 10%
• Score in HIGH risk zone (63/100)
🔔 Track XFOR — Get forecast alerts →

Market Data

Market Cap$406.52M
Shares Outstanding99.15M
Float57.41M
Cash$195.09M
Debt$54.57M
Short InterestN/A

Institutional Holdings

QoQ: ↑ 34.0% shares (2026Q1 vs prior)
82 institutional holders · 115.29M shares
#1 MORGAN STANLEY 17.68M shares
#2 PERCEPTIVE ADVISORS LLC 13.48M shares
#3 Empery Asset Management, LP 8.94M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest7.30M
Days to Cover12.8
% of Float12.7%
FINRA data as of Jul 31, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2025-12-31
xbrl XBRL CONVERTIBLE 2020-12-31
Full SEC filing analysis available with free account

Recent News

No recent news

Factual XFOR Dilution Snapshot

X4 Pharmaceuticals, Inc. (XFOR) has a DilutionScore of 63/100, rated High dilution risk. Score date: August 28, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track XFOR Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking XFOR — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for XFOR
XFOR FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.